Migraine Disorders
Information
- Disease name
- Migraine Disorders
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT06154070 | Active, not recruiting | An Open Label, Study of DaxibotulinumtoxinA for Migraine Prevention | October 24, 2023 | October 2024 | |
| NCT05499689 | Active, not recruiting | N/A | Transcutaneous Pulsed Radiofrequency in Migraine | June 22, 2021 | August 22, 2023 |
| NCT04936321 | Active, not recruiting | N/A | Intervention for Sleep and Pain in Youth: A Randomized Controlled Trial | October 1, 2021 | August 31, 2024 |
| NCT05102591 | Active, not recruiting | Phase 3 | A Pilot Clinical Trial of a New Neuromodulation Device for Acute Attacks of Migraine in Children and Adolescents | February 22, 2022 | August 29, 2024 |
| NCT04743492 | Active, not recruiting | N/A | Pain Resilience and Holistic Health Care of Migraine | April 16, 2021 | May 2024 |
| NCT05888298 | Active, not recruiting | N/A | Proximal and Distal Approach GON RFT in Migraine | September 1, 2022 | December 28, 2023 |
| NCT00319137 | Completed | Phase 2 | An Adaptive Design Trial Of GW274150 In The Treatment Of Acute Migraine | December 2005 | |
| NCT00329355 | Completed | Phase 3 | Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA) | May 2006 | November 2006 |
| NCT00329459 | Completed | Phase 3 | Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea | May 2006 | November 2006 |
| NCT00356603 | Completed | Phase 3 | Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan | June 20, 2006 | August 7, 2006 |
| NCT00382993 | Completed | Phase 3 | A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2) | December 2006 | November 2007 |
| NCT00383162 | Completed | Phase 3 | A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2) | November 2006 | October 2007 |
| NCT00385008 | Completed | Phase 3 | TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine | September 13, 2006 | November 24, 2006 |
| NCT00488514 | Completed | Phase 3 | Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents | July 13, 2007 | August 20, 2009 |
| NCT00548353 | Completed | Phase 1 | A Study of Gastric Delay in Migraine Patients (3207-003) | August 2007 | February 2010 |
| NCT00573170 | Completed | Phase 3 | TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults | February 2008 | August 2009 |
| NCT00604812 | Completed | Phase 1 | Drug Study in Pediatric Subjects With Migraines (MK0462-083 AM1) | December 17, 2007 | September 17, 2010 |
| NCT00623636 | Completed | Phase 3 | Phase 3 Study of MAP0004 in Adult Migraineurs | July 2008 | January 2011 |
| NCT00662818 | Completed | Phase 3 | Telcagepant (MK-0974) Treatment of Migraine in Participants With Stable Vascular Disease (MK-0974-034) | March 17, 2008 | September 2, 2009 |
| NCT00701389 | Completed | Phase 1 | Study to Evaluate the Safety, Tolerability, and Blood Pressure Effect of an Oral Dose of Sumatriptan Alone and in Combination With MK-0974 (Telcagepant) in Migraine Patients (0974-026) | November 20, 2007 | April 10, 2008 |
| NCT00720018 | Completed | Phase 1 | Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers | June 2008 | July 2008 |
| NCT00723983 | Completed | Phase 1 | Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period | November 2008 | September 2009 |
| NCT00724815 | Completed | Phase 3 | The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine | January 2009 | July 2009 |
| NCT00742209 | Completed | Phase 2 | Prevention Study in Adult Patients Suffering From Migraine Headaches | August 2008 | June 2010 |
| NCT00743015 | Completed | Phase 1 | Relative Bioavailability of a Single Dose of BI 44370 Tablet During and Between Migraine Attacks | September 2008 | |
| NCT00751803 | Completed | Phase 2 | BI 44370 TA in Acute Migraine Attack | August 2008 | |
| NCT00792103 | Completed | Phase 3 | An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months | January 2009 | September 2010 |
| NCT00792636 | Completed | Phase 4 | A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period | November 2008 | November 2009 |
| NCT00806546 | Completed | Phase 3 | An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months | February 2009 | May 2011 |
| NCT00843024 | Completed | Phase 3 | Migraine Study in Adolescent Patients | December 2008 | June 2010 |
| NCT00875784 | Completed | Phase 1 | An Open-label, Randomized, 3-period Crossover Study to Evaluate Sumatriptan Pharmacokinetics for a TREXIMA™ (Sumatriptan Succinate / Naproxen Sodium) Tablet Followed by IMITREX® (Sumatriptan Succinate) | May 6, 2008 | June 14, 2008 |
| NCT00883051 | Completed | Phase 2 | Dose-ranging Study of Oral COL-144 in Acute Migraine Treatment | July 2009 | February 2010 |
| NCT00930852 | Completed | A Pilot Study of Migraine and Appetite Behaviour in Children | July 2009 | August 2010 | |
| NCT00963937 | Completed | Phase 3 | Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents | September 28, 2009 | December 3, 2010 |
| NCT00989625 | Completed | Phase 1 | A Pharmacokinetic Study to Evaluate TREXIMET in Adolescents With Migraine and Healthy Subjects Administered at Three Doses. | November 4, 2008 | September 10, 2009 |
| NCT01050465 | Completed | N/A | MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use | May 2009 | December 2010 |
| NCT01059604 | Completed | Sumatriptan and Naratriptan Pregnancy Registry | December 2001 | April 2013 | |
| NCT01080677 | Completed | Phase 2 | Caffeine/Propranolol Intervention for Acute Migraine | January 2007 | December 2009 |
| NCT01259947 | Completed | Phase 2 | Lippia Alba for Migraine Prophylaxis and Treatment | July 2006 | October 2010 |
| NCT01286207 | Completed | Phase 3 | Long-Term Exposure to Rizatriptan 5-mg and 10-mg Oral Tablet (Combined Extension Protocols MK-0462-022, MK-0462-025, MK-0462-029) | March 1995 | May 1997 |
| NCT01332383 | Completed | Special Drug Use Investigation for AMERGE® Tablet (Long-term) | May 2009 | October 2013 | |
| NCT01332500 | Completed | Treximet ™ Pharmacy Budget Impact Model Database Validation Study | July 2009 | March 2010 | |
| NCT00156910 | Completed | Phase 3 | A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent Headaches | February 2006 | July 2008 |
| NCT01376193 | Completed | Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet | April 2009 | October 2011 | |
| NCT01381497 | Completed | Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy | March 2010 | October 2011 | |
| NCT01381523 | Completed | A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data | November 2010 | June 2011 | |
| NCT01432379 | Completed | BOTOX® Prophylaxis in Patients With Chronic Migraine | September 9, 2011 | May 12, 2015 | |
| NCT01435941 | Completed | Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine | September 2009 | February 2011 | |
| NCT01511497 | Completed | Phase 1 | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study Of PF-04427429 In Healthy Women Volunteers | October 2011 | January 2013 |
| NCT01516892 | Completed | Phase 4 | A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine | December 2011 | November 2015 |
| NCT01579383 | Completed | Phase 1 | Safety Tolerability and Pharmacokinetics of ALD403 | April 2012 | April 2013 |
| NCT01376141 | Completed | Drug Use Investigation for IMIGRAN Tablet | September 2001 | November 2005 | |
| NCT00168428 | Completed | Phase 3 | A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent Headaches | March 2006 | August 2008 |
| NCT00240617 | Completed | Phase 3 | Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks | October 2005 | June 2006 |
| NCT00240630 | Completed | Phase 3 | Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks | October 2005 | June 2006 |
| NCT00242866 | Completed | Phase 2 | Use Of GW274150 In The Prophylactic Treatment Of Migraine | October 2005 | September 2007 |
| NCT00297336 | Completed | An Observational Study Evaluating the Safety of Topiramate for the Prevention of Migraine | March 2005 | February 2007 | |
| NCT01648530 | Completed | Chronic Migraine Epidemiology and Outcomes Study | July 2012 | November 2013 | |
| NCT01662492 | Completed | Phase 3 | A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine | October 2012 | August 2016 |
| NCT01686581 | Completed | An Observational Study of BOTOX® as Headache Prophylaxis for Chronic Migraine | July 23, 2012 | October 12, 2016 | |
| NCT01791400 | Completed | Phase 2 | Effect of Metoclopramide Versus Sumatriptan for Emergency Department Treatment of Migraine Headache | July 2009 | November 2010 |
| NCT01828684 | Completed | N/A | Thin Film Spectacle Coatings to Reduce Light Sensitivity and Headaches in Patients With Migraine | March 2013 | February 2014 |
| NCT01946126 | Completed | A Retrospective Chart Review to Evaluate Diagnosis and Treatment of Chronic Migraine and Headache | March 2014 | April 2014 | |
| NCT01976611 | Completed | Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Chronic Migraine in Korea | June 2012 | February 2015 | |
| NCT02012790 | Completed | N/A | Nutrition for Migraine Prevention | July 2014 | May 11, 2018 |
| NCT02104765 | Completed | Phase 1 | A Study of LY2951742 in Healthy Japanese and Caucasian Participants | June 2014 | January 2015 |
| NCT02147561 | Completed | Phase 4 | A Safety and Efficacy Study of BOTOX® in Korean Adults With Chronic Migraine | July 2014 | February 2015 |
| NCT02183220 | Completed | Phase 3 | Efficacy and Tolerability of Metamizol in Patients With Episodic Moderate Headache | October 1998 | |
| NCT02183688 | Completed | Phase 3 | Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients | September 1998 | |
| NCT02191579 | Completed | Phase 4 | Efficacy and Safety Study of BOTOX® Compared to Topiramate for the Prevention of Chronic Migraine in Adults | August 5, 2014 | September 1, 2017 |
| NCT02198339 | Completed | Phase 2 | Efficacy, Safety, Tolerability and Pharmacokinetics of BIBN 4096 BS Versus Placebo in the Treatment of a Single Attack of Acute Migraine Headache | February 1999 | |
| NCT02214550 | Completed | Phase 4 | Chronic Pain Risk Associated With Menstrual Period Pain | July 2014 | January 2021 |
| NCT02259075 | Completed | Phase 1/Phase 2 | Botox Injection in Treatment of Chronic Migraine | February 2015 | March 2016 |
| NCT02275117 | Completed | Phase 2 | A Multicenter Assessment of ALD403 in Chronic Migraine | October 2014 | November 2016 |
| NCT02314351 | Completed | Phase 4 | Intravenous Metoclopramide in the Acute Treatment of Migraine: A Double-blind, Randomized, Placebo-controlled Trial | December 2014 | January 2017 |
| NCT02424318 | Completed | Phase 4 | Topiramate and Cerebrovascular Response in Migraineurs | December 2008 | December 2010 |
| NCT02502123 | Completed | Patient Reported Outcomes in Patients With Chronic Migraine Treated With BOTOX® | July 2, 2015 | January 29, 2019 | |
| NCT02549885 | Completed | N/A | Efficacy of Proprioceptive Neuromuscular Facilitation in Pain Relief | April 2016 | August 2017 |
| NCT02559895 | Completed | Phase 3 | A Multicenter Assessment of ALD403 in Frequent Episodic Migraine | September 2015 | December 2017 |
| NCT02564822 | Completed | Effects of the Visual Stimulation on the Motor and Visual Cortex in Migraneurs With and Without Aura | July 2015 | August 2016 | |
| NCT02565186 | Completed | Phase 3 | An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine | October 7, 2015 | August 20, 2019 |
| NCT02747511 | Completed | Phase 4 | IV Haloperidol for the Treatment of Headache in the ED | October 2015 | October 2017 |
| NCT02766517 | Completed | Early Phase 1 | Biomarker Study in Participants With Migraine | September 28, 2016 | January 1, 2017 |
| NCT02870725 | Completed | N/A | CBT Depression Intervention for Co-Occurring Chronic Headache | November 2016 | July 1, 2017 |
| NCT02910921 | Completed | Individualized Prediction of Migraine Attacks Using a Mobile Phone App and Fitbit | November 2016 | July 31, 2018 | |
| NCT02974153 | Completed | Phase 3 | Evaluation of ALD403 (Eptinezumab) in the Prevention of Chronic Migraine | November 2016 | April 2018 |
| NCT03055767 | Completed | Phase 2 | Effectiveness of Onabotulinumtoxin A (Botox) in Pediatric Patients Experiencing Migraines: A Study in the Pediatric Pain Population | March 1, 2017 | April 20, 2020 |
| NCT03137147 | Completed | N/A | Intervention for Sleep and Pain in Youth | October 1, 2016 | December 30, 2017 |
| NCT03157739 | Completed | N/A | MigraineManager: An Individualized Self-Management Tool for Adolescents With Migraine | December 6, 2017 | April 30, 2018 |
| NCT03177616 | Completed | N/A | Integrative Migraine Pain Alleviation Through Chiropractic Therapy | June 7, 2017 | November 4, 2022 |
| NCT03229798 | Completed | Phase 1 | Sofusa System With Sumatriptan (KC5010) Phase 1 Dose Escalation Safety and PK Study (KCC-SMT-002) | January 17, 2018 | March 28, 2018 |
| NCT03247790 | Completed | Phase 1 | A Study of Lasmiditan in Participants With Migraine | August 16, 2017 | January 15, 2018 |
| NCT03435185 | Completed | N/A | Greater Occipital and Supraorbital Nerve Blockade in Migraine Patients | September 1, 2014 | June 1, 2016 |
| NCT03479060 | Completed | N/A | Continue or Stop Applying Wet Cupping (Al-Hijamah) in Migraine | January 3, 2017 | March 1, 2018 |
| NCT03543254 | Completed | Phase 2 | "Follow the Sutures". A New Procedure for Injection of Botulinum Toxin for Chronic Migraine | May 1, 2018 | January 1, 2021 |
| NCT03588364 | Completed | N/A | The Role of Osteopathic Manipulation in the the Management of Post-traumatic Migraine | September 15, 2016 | June 2019 |
| NCT03606356 | Completed | Phase 4 | Sustained onabotulinumtoxinA Therapeutic Benefits in Patients With Chronic Migraine | April 1, 2015 | April 1, 2018 |
| NCT03626805 | Completed | Muscle Tenderness and Hardness in Migraine Patients | August 13, 2017 | December 18, 2018 | |
| NCT03662295 | Completed | Stroke-like Migraine Attacks After Radiation Treatment (SMART) Syndrome Language Intervention | September 3, 2018 | November 13, 2019 | |
| NCT03716505 | Completed | N/A | Non-invasive Vagus Nerve Stimulation for the Prevention of Migraines | November 2, 2018 | September 9, 2020 |
| NCT03775252 | Completed | N/A | A Ketogenic Diet Acts on Cortical But Not Subcortical Responsivity in Migraineurs | January 1, 2017 | November 30, 2017 |
| NCT03874351 | Completed | N/A | A Study of Home-Delivered Neurostimulation for Migraine | April 22, 2019 | May 12, 2020 |
| NCT03977649 | Completed | Phase 4 | A Functional MRI Study on Erenumab Treatment Effects in Episodic Migraine Patients | July 30, 2019 | July 5, 2021 |
| NCT04084314 | Completed | Phase 4 | Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study | September 30, 2019 | March 13, 2023 |
| NCT04091321 | Completed | Association Between Chronic Headache and Back Pain With Childbirth | September 13, 2019 | February 26, 2020 | |
| NCT04129567 | Completed | N/A | Transnasal Therapy for Acute Migraine Attack | August 15, 2018 | November 15, 2019 |
| NCT04220606 | Completed | N/A | 1H Magnetic Resonance Spectroscopy in Migraine Patients | April 2015 | April 2016 |
| NCT04228809 | Completed | N/A | tDCS in Chronic Migraine With Medication Overuse (Edisom) | December 1, 2015 | May 30, 2018 |
| NCT04272229 | Completed | N/A | Cognitive Function and Autonomic Regulation in Patients With Migraine | January 15, 2020 | December 15, 2020 |
| NCT04319445 | Completed | N/A | Mindfulness During COVID-19 | March 23, 2020 | July 28, 2020 |
| NCT04491474 | Completed | Phase 4 | Comparison of Great Occipital Nerve and Supraorbital Nerve Blockade Methods at Treatment of Acute Migraine Attack in the Emergency Department | August 15, 2020 | March 14, 2021 |
| NCT04509141 | Completed | N/A | Acupuncture as Migraine Prophylaxis in Reducing Frequency, Duration and Intensity of Migraine With Minimum Acupoint, Seen up to Eight Weeks From Baseline | July 5, 2019 | August 30, 2019 |
| NCT04553445 | Completed | N/A | Temporal, Environmental, and Genetic Factors Regulating Exercise and Migraine | November 23, 2020 | May 31, 2022 |
| NCT04976725 | Completed | N/A | Comparison of Craniosacral Therapy and Myofacial Relaxation Techniques in People Diagnosed With Migraine | February 10, 2021 | September 20, 2021 |
| NCT05052008 | Completed | Management of Migraine Using Enerumab and Traditional Therapy at the Time of COVID-19 | August 15, 2020 | September 10, 2021 | |
| NCT05153876 | Completed | An Open Internet-based Survey and Natural Language Processing Project Analysing Written Monologues by Headache Patients | October 11, 2021 | January 1, 2024 | |
| NCT05369910 | Completed | N/A | How Can we Treat Photophobia in Migraine | April 1, 2015 | September 30, 2019 |
| NCT05632133 | Completed | Phase 3 | The Lacosamide's Effect on Calcitonin Gene-related Peptide in Migraine Patients | June 1, 2022 | August 10, 2023 |
| NCT05658185 | Completed | N/A | Migraine Difficult to Treat: the Importance of Psychological Care in the Chronic Patient | October 29, 2022 | December 31, 2023 |
| NCT05747911 | Completed | Dietary Advanced Glycation End Products and Migraine | February 1, 2022 | March 1, 2023 | |
| NCT05851781 | Completed | Phase 3 | Lacosamide Versus Propranolol in Migraine | June 1, 2022 | August 30, 2023 |
| NCT06061588 | Completed | N/A | "Potential Effects of Virtual Reality Technology on the Treatment of Migraine-Type Headaches" | September 15, 2023 | March 10, 2024 |
| NCT06077006 | Completed | The Impact of nCoV-2019 on Children With Migraine | April 1, 2021 | July 30, 2023 | |
| NCT06197542 | Completed | N/A | Effects of Active Release Technique and Instrument Assisted Soft Tissue Mobilization in Patients With Migraine | April 10, 2023 | November 15, 2023 |
| NCT06412965 | Completed | Reliability of Rimegepant for the Acute Treatment of Migraine | January 2, 2024 | January 3, 2024 | |
| NCT06212661 | Enrolling by invitation | Migraine Medication Effects on Urinary Symptoms | April 5, 2024 | May 2026 | |
| NCT04373330 | Not yet recruiting | N/A | Healthy Living Partnerships for Veterans With Migraine | June 2024 | December 2024 |
| NCT06054399 | Not yet recruiting | N/A | Education on Migraine in Pregnant Women | December 1, 2023 | November 30, 2025 |
| NCT05690737 | Not yet recruiting | N/A | Tai Chi for the Prophylaxis of Episodic Migraine: the Efficacy Examination and Mechanism Exploration | May 1, 2023 | September 30, 2025 |
| NCT06426316 | Not yet recruiting | N/A | The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology. | May 15, 2024 | April 30, 2027 |
| NCT06432127 | Not yet recruiting | Phase 4 | Role of Ultrasound Guide Greater Occipital Nerve Block at Second Cervical Vertebra in Migraine Headache Prophylaxis | May 30, 2024 | January 2027 |
| NCT05675189 | Not yet recruiting | Exploring Clinical Trial Experiences of Patients With Migraine | January 2025 | January 2027 | |
| NCT05888766 | Not yet recruiting | Predict the Response to Acute Treatment of Migraine With Rimegepant 75 mg | July 1, 2023 | September 30, 2024 | |
| NCT05570149 | Recruiting | EptinezuMaB in ReAl-world evidenCE: Multicenter, Real Life, Cohort Study in Migraine. | January 1, 2023 | December 2026 | |
| NCT03472092 | Recruiting | Phase 2 | Mind and Body Approaches to Pain Reduction in Youth With Migraine | October 2, 2018 | June 30, 2025 |
| NCT06243692 | Recruiting | Phase 3 | Lacosamide Versus Topiramate in Migraine | February 1, 2024 | February 25, 2025 |
| NCT06035458 | Recruiting | Potential Osteocatabolic Effect Caused by Anti-CGRP mAbs in Migraine Patients Treated With Anti-CGRP mAbs - an Observational Pilot Project With Prospectively Collected Health Related Data | April 13, 2022 | March 31, 2024 | |
| NCT06244823 | Recruiting | Phase 4 | The FreMRI Study: Advanced MRI on Migraine Patients Treated With Fremanezumab | March 1, 2023 | January 1, 2025 |
| NCT05797012 | Recruiting | N/A | The Association Among Headache Severity, Head Posture, Cervical Muscle Endurance, and Neck Disorders in Individuals With Migraine | April 1, 2023 | December 1, 2023 |
| NCT06050382 | Recruiting | N/A | Progressive Relaxation Training Effect On Pain, Activity And Social Participation In Women With Tension-Type Headache And Migraine | November 8, 2022 | July 10, 2024 |
| NCT06459635 | Recruiting | Migraine Attack Pain Phase Prediction Study | October 9, 2023 | December 2025 | |
| NCT04567355 | Recruiting | Phase 2 | Migraine Manager (R01) | June 10, 2021 | May 31, 2025 |
| NCT04693533 | Recruiting | Phase 4 | Fremanezumab, Migraine and Sleep | July 29, 2021 | May 30, 2024 |
| NCT04715685 | Recruiting | N/A | Mind Body Balance for Pediatric Migraine | March 9, 2021 | May 31, 2025 |
| NCT05889624 | Recruiting | N/A | Responding With Evidence and Access for Childhood Headaches | August 22, 2023 | December 31, 2027 |
| NCT05415020 | Recruiting | N/A | Determining the Utility of a Behavioral Intervention in Chronic Migraine | June 29, 2022 | February 3, 2025 |
| NCT05780450 | Recruiting | N/A | Effectiveness of Transcranial Direct Current in Patients With Persistent COVID-19 With Headaches and Chronic Pain. | April 1, 2023 | July 2023 |
| NCT05706077 | Recruiting | N/A | Effects of tDCS and Physical Therapy in Chronic Migraine | March 25, 2023 | September 2024 |
| NCT04151472 | Recruiting | Phase 3 | Idebenone for the Preventive Treatment of Migraine | December 8, 2021 | December 31, 2025 |
| NCT05528081 | Recruiting | Longitudinal Study of the Patients With Medication-overuse Headache or Migraine That Completed Baseline MRI | October 1, 2022 | October 31, 2025 | |
| NCT05755698 | Recruiting | N/A | Emotional Awareness and Expression Therapy (EAET) for Migraine | March 4, 2023 | March 4, 2024 |
| NCT05342493 | Recruiting | Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term Use | April 20, 2022 | June 22, 2029 | |
| NCT04069897 | Recruiting | Phase 3 | Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Migraine | October 1, 2019 | December 2024 |
| NCT05837650 | Recruiting | N/A | Emotional Awareness and Expression Therapy (EAET) as a Novel Migraine Treatment | April 1, 2023 | March 31, 2024 |
| NCT06248931 | Recruiting | Phase 3 | Valproate Versus Topiramate in Migraine | February 1, 2024 | February 20, 2025 |
| NCT06267664 | Recruiting | Real-world Effectiveness and Tolerability of Triptans-Ditans-Gepants (TRIDIGEP) | December 4, 2023 | December 1, 2024 | |
| NCT06155123 | Recruiting | HD-EEG Connectivity Changes in Migraine Patients Undergoing Treatment With Anti-CGRP mAbs | January 14, 2020 | June 2024 | |
| NCT05718310 | Recruiting | N/A | Habituation of the Nociceptive Blink Reflex in Experimentally Induced Migraine Attack | November 1, 2022 | December 2024 |
| NCT03026101 | Recruiting | N/A | Understanding the Pathophysiology of Migraine Pain | January 2017 | June 2026 |
| NCT05244889 | Recruiting | N/A | Digital CBTI for Comorbid Insomnia in Chronic Migraine | January 31, 2022 | September 21, 2024 |
| NCT04748601 | Recruiting | Phase 4 | Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old | February 19, 2021 | September 2026 |
| NCT04050293 | Recruiting | Phase 4 | Therapy for Migraine Prevention in Children 6-11 Years of Age | July 14, 2020 | December 31, 2024 |
| NCT01581281 | Terminated | Phase 3 | The Childhood and Adolescent Migraine Prevention Study | June 2012 | January 2016 |
| NCT01775735 | Terminated | N/A | Occipital Nerve Stimulation (ONS) for Migraine: OPTIMISE | April 10, 2013 | January 19, 2017 |
| NCT02758990 | Terminated | N/A | Interventional Testing of Gene-environment Interactions Via the Verifomics Mobile Application | March 2016 | November 23, 2016 |
| NCT03762902 | Terminated | Predicting Migraine Attacks Based on Environmental and Behavioral Changes as Detected From the Smartphone | April 30, 2019 | September 1, 2019 | |
| NCT02169830 | Terminated | N/A | Trial of Nortriptyline and Topiramate in the Initial Treatment of Vestibular Migraine | August 22, 2014 | October 30, 2019 |
| NCT04106505 | Terminated | N/A | Efficacy of a Novel App-based Migraine Treatment Platform - a Pilot Study | January 11, 2019 | April 29, 2020 |
| NCT00267371 | Terminated | Phase 3 | ESCAPE Migraine Trial | November 2005 | March 2012 |
| NCT01942486 | Terminated | N/A | Thin Film Spectacle Coatings to Reduce Light Sensitivity and Headaches in Child and Adolescent Patients With Migraine | January 2014 | April 2018 |
| NCT03418766 | Unknown status | The Relationship Between Right-to-left Shunt and Brain White Matter Lesions in Patients With Migraine | June 15, 2018 | December 30, 2020 | |
| NCT00285402 | Unknown status | Phase 2 | Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine | May 2007 | June 2008 |
| NCT04287140 | Unknown status | N/A | The Effect of Intravenous Fluid Therapy in Acute Migraine Attacks | April 1, 2020 | November 1, 2021 |
| NCT01228552 | Unknown status | Phase 3 | The Efficacy and Safety of Intra-oral Topical Ketoprofen for the Treatment of Acute Migraine | December 2011 | January 2012 |
| NCT04828941 | Unknown status | N/A | My Healthy Diary - An Electronic Diary for Remote Migraine Monitoring | March 28, 2021 | November 1, 2021 |
| NCT02562196 | Unknown status | Phase 2 | tDCS for the Treatment of Migraine | March 2016 | April 2018 |
| NCT02562222 | Unknown status | Phase 2 | Optimized tDCS for the Treatment of Migraine | May 2016 | April 2018 |
| NCT00901953 | Unknown status | Vestibular System in Migrainous Vertigo Patients | May 2007 | September 2009 | |
| NCT04976985 | Unknown status | N/A | Osteopathic Manipulative Treatment and Migraine Headaches | October 2, 2018 | March 30, 2022 |
| NCT05048914 | Unknown status | Migraine Abortive Treatment | September 3, 2019 | January 1, 2022 | |
| NCT02779959 | Unknown status | Phase 3 | Buccal Prochlorperazine Versus Intravenous Prochlorperazine for Migraine Headaches, a RCT | April 2016 | April 2018 |
| NCT02817139 | Unknown status | Phase 1/Phase 2 | Transcranial Direct Current Simulation in Chronic Migraine | June 2016 | September 2016 |
| NCT03190044 | Unknown status | N/A | Magnesium, Partenium, Andrographis, Co-enzyme Q10 and Riboflavin (PACR) in Migraine Prophylaxis | June 6, 2017 | December 31, 2019 |
| NCT03220113 | Unknown status | Phase 1/Phase 2 | Treatment of Chronic Migraine Headaches. | July 1, 2017 | July 1, 2019 |
| NCT00363506 | Unknown status | Phase 4 | American Migraine Prevention Study | January 2006 | December 2008 |
| NCT03419715 | Unknown status | Phase 2 | Topical Bimatoprost in the Treatment of Migraine | January 5, 2018 | June 30, 2019 |
| NCT03504150 | Unknown status | N/A | Testing myWHI: Online Self-help Programs for Headaches | May 4, 2018 | May 1, 2020 |
| NCT03632928 | Unknown status | Day to Day Variation of Pressure Pain Threshold and Muscle Hardness | September 2018 | March 2019 | |
| NCT03772860 | Unknown status | Defining the Sympathetic Skin Response of Migraineurs in the Facial Area | December 2018 | December 2019 | |
| NCT03193359 | Withdrawn | Phase 3 | Open Label Study of BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Patients With Chronic Migraine | January 15, 2018 | September 9, 2021 |
| NCT03193346 | Withdrawn | Phase 3 | BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Participants With Chronic Migraine | July 3, 2017 | March 25, 2021 |
| NCT01653522 | Withdrawn | N/A | The Impact of Triptan and Doxycycline on Neuroinflammatory Biomarkers in Acute Migraine | July 2012 | July 2014 |
| NCT00447369 | Withdrawn | Phase 3 | Efficacy of Pregabalin in Migraine Prevention | May 2007 | March 2008 |
| NCT02578719 | Withdrawn | Phase 4 | Greater Occipital Nerve (GON) Block Effectivity in the Treatment of Chronic Migraine: 6 Months Follow up | July 2016 | July 2018 |
| NCT03578354 | Withdrawn | Phase 2 | 4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine | January 2019 | January 2024 |
| NCT03484871 | Withdrawn | Resting-state Functional Connectivity Changes During Migraine Treatment | May 2016 | April 2019 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D008881